Search

Search Constraints

You searched for: Author/Creator Beslija, Semir

Search Results

2. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. (August 2020)

3. Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial. Issue 9 (September 2016)

5. Long-term outcome of GIST patients treated with delayed imatinib therapy. (June 2017)